{
  "retracted": false,
  "timestamp": 1391299200000,
  "updates": [
    {
      "timestamp": 1574593533698,
      "identifier": {
        "doi": "10.1007/s10072-014-1649-0"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s10072-013-1616-1"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group"
}
